Biggest Market Movers - 12/16/2011

Venture Investors Grow Grim
Podcast: December 19, 2011 Read More
Congress Axes Rule that Restricted Innovation Funding
Change opens the door to new money for VC-backed companies. Read More
BioSante’s "Female Viagra" Fails Late-Stage Trials
Trial shows that placebo performs as well as LibiGel. Read More
Healthcare Reform Extends Coverage to 2.5M Young Adults
Affordable Care Act paying dividends. Read More
AstraZeneca Strikes Pact with UK Medical Research Council
New collaboration gives academic community access to drug candidates. Read More
SEC Charges Stiefel Labs and its Former CEO with Fraud
The weekly round-up of failed trials, missed targets, and other business mishaps. Read More
Abbott Licenses Reata Pipeline for $400M
Even the partnering agreements are big in Texas. Read More
Amgen CEO and Research Chief to Step Down
California biotech promotes from within to fill leadership roles. Read More
Combining Talents to Fund Early Stage Companies
Venture firm and biopharma join together to invest in early-stage rare disease therapies. Read More
Quintiles Launches China CRO
Kun Tuo to be a one-stop shop for biopharma R&D.; Read More

[Please login to post comments]